ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nucleic Acid Multiplex Assay Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-18D9505
Home | Market Reports | Science
Global Nucleic Acid Multiplex Assay Market Insights Forecast to 2028
BUY CHAPTERS

Global Nucleic Acid Multiplex Assay Market Research Report 2025

Code: QYRE-Auto-18D9505
Report
June 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Luminex Corporation (US)
Thermo Fisher Scientific Inc. (US)
Illumina, Inc. (US)
Bio-Rad Laboratories, Inc. (US)
QIAGEN N.V. (Netherlands)
Abcam plc (UK)
Becton Dickinson and Company (US)
Merck KGaA Germany
Agilent Technologies Inc. (US)
Meso Scale Diagnostics (US)
Randox Laboratories (UK)
Quanterix (US)
Bio-Techne Corporation (US)
Olink (Sweden)
DiaSorin S.p.A. (Italy)
Seegene (South Korea)
Promega Corporation (US)
Siemens Healthineers (Germany)
Perkinelmer Inc (US)
Shimadzu Biotech (Japan)
Antigenix America, Inc. (US)
Enzo Life Sciences, Inc. (US)
Boster Biological Technology(US)
AYOXXA Biosystems GmbH (Germany)
Cayman Chemical Company (US)

Nucleic Acid Multiplex Assay Market

The global market for Nucleic Acid Multiplex Assay was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Nucleic Acid Multiplex Assay is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nucleic Acid Multiplex Assay is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Nucleic Acid Multiplex Assay in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Nucleic Acid Multiplex Assay include Luminex Corporation (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc (US), Bio-Rad Laboratories, Inc. (US), Qiagen N.V. (Netherlands), Abcam plc (UK), Becton, Dickinson and Company (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Meso Scale Diagnostics (US), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Multiplex Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Multiplex Assay.
The Nucleic Acid Multiplex Assay market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acid Multiplex Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Multiplex Assay companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Nucleic Acid Multiplex Assay Market Report

Report Metric Details
Report Name Nucleic Acid Multiplex Assay Market
Segment by Type
  • Planar Nucleic Acid Assays
  • Bead-Based Nucleic Acid Assays
  • Other Nucleic Acid Assays
Segment by Application
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Research Institutes
  • Reference Laboratories
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Luminex Corporation (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc (US), Bio-Rad Laboratories, Inc. (US), Qiagen N.V. (Netherlands), Abcam plc (UK), Becton, Dickinson and Company (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Meso Scale Diagnostics (US), Randox Laboratories (UK), Quanterix (US), Bio-Techne Corporation (US), Olink (Sweden), DiaSorin S.p.A. (Italy), Seegene (South Korea), Promega Corporation (US), Siemens Healthineers (Germany), PerkinElmer, Inc. (US), Shimadzu Biotech (Japan), Antigenix America, Inc. (US), Enzo Life Sciences, Inc. (US), Boster Biological Technology (US), AYOXXA Biosystems GmbH (Germany), Cayman Chemical Company (US)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Nucleic Acid Multiplex Assay company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nucleic Acid Multiplex Assay Market report?

Ans: The main players in the Nucleic Acid Multiplex Assay Market are Luminex Corporation (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc (US), Bio-Rad Laboratories, Inc. (US), Qiagen N.V. (Netherlands), Abcam plc (UK), Becton, Dickinson and Company (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Meso Scale Diagnostics (US), Randox Laboratories (UK), Quanterix (US), Bio-Techne Corporation (US), Olink (Sweden), DiaSorin S.p.A. (Italy), Seegene (South Korea), Promega Corporation (US), Siemens Healthineers (Germany), PerkinElmer, Inc. (US), Shimadzu Biotech (Japan), Antigenix America, Inc. (US), Enzo Life Sciences, Inc. (US), Boster Biological Technology (US), AYOXXA Biosystems GmbH (Germany), Cayman Chemical Company (US)

What are the Application segmentation covered in the Nucleic Acid Multiplex Assay Market report?

Ans: The Applications covered in the Nucleic Acid Multiplex Assay Market report are Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Other

What are the Type segmentation covered in the Nucleic Acid Multiplex Assay Market report?

Ans: The Types covered in the Nucleic Acid Multiplex Assay Market report are Planar Nucleic Acid Assays, Bead-Based Nucleic Acid Assays, Other Nucleic Acid Assays

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Multiplex Assay Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Planar Nucleic Acid Assays
1.2.3 Bead-Based Nucleic Acid Assays
1.2.4 Other Nucleic Acid Assays
1.3 Market by Application
1.3.1 Global Nucleic Acid Multiplex Assay Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Multiplex Assay Market Perspective (2020-2031)
2.2 Global Nucleic Acid Multiplex Assay Growth Trends by Region
2.2.1 Global Nucleic Acid Multiplex Assay Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nucleic Acid Multiplex Assay Historic Market Size by Region (2020-2025)
2.2.3 Nucleic Acid Multiplex Assay Forecasted Market Size by Region (2026-2031)
2.3 Nucleic Acid Multiplex Assay Market Dynamics
2.3.1 Nucleic Acid Multiplex Assay Industry Trends
2.3.2 Nucleic Acid Multiplex Assay Market Drivers
2.3.3 Nucleic Acid Multiplex Assay Market Challenges
2.3.4 Nucleic Acid Multiplex Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Multiplex Assay Players by Revenue
3.1.1 Global Top Nucleic Acid Multiplex Assay Players by Revenue (2020-2025)
3.1.2 Global Nucleic Acid Multiplex Assay Revenue Market Share by Players (2020-2025)
3.2 Global Nucleic Acid Multiplex Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nucleic Acid Multiplex Assay Revenue
3.4 Global Nucleic Acid Multiplex Assay Market Concentration Ratio
3.4.1 Global Nucleic Acid Multiplex Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Multiplex Assay Revenue in 2024
3.5 Global Key Players of Nucleic Acid Multiplex Assay Head office and Area Served
3.6 Global Key Players of Nucleic Acid Multiplex Assay, Product and Application
3.7 Global Key Players of Nucleic Acid Multiplex Assay, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Multiplex Assay Breakdown Data by Type
4.1 Global Nucleic Acid Multiplex Assay Historic Market Size by Type (2020-2025)
4.2 Global Nucleic Acid Multiplex Assay Forecasted Market Size by Type (2026-2031)
5 Nucleic Acid Multiplex Assay Breakdown Data by Application
5.1 Global Nucleic Acid Multiplex Assay Historic Market Size by Application (2020-2025)
5.2 Global Nucleic Acid Multiplex Assay Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nucleic Acid Multiplex Assay Market Size (2020-2031)
6.2 North America Nucleic Acid Multiplex Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nucleic Acid Multiplex Assay Market Size by Country (2020-2025)
6.4 North America Nucleic Acid Multiplex Assay Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Multiplex Assay Market Size (2020-2031)
7.2 Europe Nucleic Acid Multiplex Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nucleic Acid Multiplex Assay Market Size by Country (2020-2025)
7.4 Europe Nucleic Acid Multiplex Assay Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Multiplex Assay Market Size (2020-2031)
8.2 Asia-Pacific Nucleic Acid Multiplex Assay Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Region (2020-2025)
8.4 Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Multiplex Assay Market Size (2020-2031)
9.2 Latin America Nucleic Acid Multiplex Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nucleic Acid Multiplex Assay Market Size by Country (2020-2025)
9.4 Latin America Nucleic Acid Multiplex Assay Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Multiplex Assay Market Size (2020-2031)
10.2 Middle East & Africa Nucleic Acid Multiplex Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country (2020-2025)
10.4 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Luminex Corporation (US)
11.1.1 Luminex Corporation (US) Company Details
11.1.2 Luminex Corporation (US) Business Overview
11.1.3 Luminex Corporation (US) Nucleic Acid Multiplex Assay Introduction
11.1.4 Luminex Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.1.5 Luminex Corporation (US) Recent Development
11.2 Thermo Fisher Scientific Inc. (US)
11.2.1 Thermo Fisher Scientific Inc. (US) Company Details
11.2.2 Thermo Fisher Scientific Inc. (US) Business Overview
11.2.3 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.2.4 Thermo Fisher Scientific Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.2.5 Thermo Fisher Scientific Inc. (US) Recent Development
11.3 Illumina, Inc (US)
11.3.1 Illumina, Inc (US) Company Details
11.3.2 Illumina, Inc (US) Business Overview
11.3.3 Illumina, Inc (US) Nucleic Acid Multiplex Assay Introduction
11.3.4 Illumina, Inc (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.3.5 Illumina, Inc (US) Recent Development
11.4 Bio-Rad Laboratories, Inc. (US)
11.4.1 Bio-Rad Laboratories, Inc. (US) Company Details
11.4.2 Bio-Rad Laboratories, Inc. (US) Business Overview
11.4.3 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.4.4 Bio-Rad Laboratories, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.4.5 Bio-Rad Laboratories, Inc. (US) Recent Development
11.5 Qiagen N.V. (Netherlands)
11.5.1 Qiagen N.V. (Netherlands) Company Details
11.5.2 Qiagen N.V. (Netherlands) Business Overview
11.5.3 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Introduction
11.5.4 Qiagen N.V. (Netherlands) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.5.5 Qiagen N.V. (Netherlands) Recent Development
11.6 Abcam plc (UK)
11.6.1 Abcam plc (UK) Company Details
11.6.2 Abcam plc (UK) Business Overview
11.6.3 Abcam plc (UK) Nucleic Acid Multiplex Assay Introduction
11.6.4 Abcam plc (UK) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.6.5 Abcam plc (UK) Recent Development
11.7 Becton, Dickinson and Company (US)
11.7.1 Becton, Dickinson and Company (US) Company Details
11.7.2 Becton, Dickinson and Company (US) Business Overview
11.7.3 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Introduction
11.7.4 Becton, Dickinson and Company (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.7.5 Becton, Dickinson and Company (US) Recent Development
11.8 Merck KGaA (Germany)
11.8.1 Merck KGaA (Germany) Company Details
11.8.2 Merck KGaA (Germany) Business Overview
11.8.3 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Introduction
11.8.4 Merck KGaA (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.8.5 Merck KGaA (Germany) Recent Development
11.9 Agilent Technologies, Inc. (US)
11.9.1 Agilent Technologies, Inc. (US) Company Details
11.9.2 Agilent Technologies, Inc. (US) Business Overview
11.9.3 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.9.4 Agilent Technologies, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.9.5 Agilent Technologies, Inc. (US) Recent Development
11.10 Meso Scale Diagnostics (US)
11.10.1 Meso Scale Diagnostics (US) Company Details
11.10.2 Meso Scale Diagnostics (US) Business Overview
11.10.3 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Introduction
11.10.4 Meso Scale Diagnostics (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.10.5 Meso Scale Diagnostics (US) Recent Development
11.11 Randox Laboratories (UK)
11.11.1 Randox Laboratories (UK) Company Details
11.11.2 Randox Laboratories (UK) Business Overview
11.11.3 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Introduction
11.11.4 Randox Laboratories (UK) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.11.5 Randox Laboratories (UK) Recent Development
11.12 Quanterix (US)
11.12.1 Quanterix (US) Company Details
11.12.2 Quanterix (US) Business Overview
11.12.3 Quanterix (US) Nucleic Acid Multiplex Assay Introduction
11.12.4 Quanterix (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.12.5 Quanterix (US) Recent Development
11.13 Bio-Techne Corporation (US)
11.13.1 Bio-Techne Corporation (US) Company Details
11.13.2 Bio-Techne Corporation (US) Business Overview
11.13.3 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Introduction
11.13.4 Bio-Techne Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.13.5 Bio-Techne Corporation (US) Recent Development
11.14 Olink (Sweden)
11.14.1 Olink (Sweden) Company Details
11.14.2 Olink (Sweden) Business Overview
11.14.3 Olink (Sweden) Nucleic Acid Multiplex Assay Introduction
11.14.4 Olink (Sweden) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.14.5 Olink (Sweden) Recent Development
11.15 DiaSorin S.p.A. (Italy)
11.15.1 DiaSorin S.p.A. (Italy) Company Details
11.15.2 DiaSorin S.p.A. (Italy) Business Overview
11.15.3 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Introduction
11.15.4 DiaSorin S.p.A. (Italy) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.15.5 DiaSorin S.p.A. (Italy) Recent Development
11.16 Seegene (South Korea)
11.16.1 Seegene (South Korea) Company Details
11.16.2 Seegene (South Korea) Business Overview
11.16.3 Seegene (South Korea) Nucleic Acid Multiplex Assay Introduction
11.16.4 Seegene (South Korea) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.16.5 Seegene (South Korea) Recent Development
11.17 Promega Corporation (US)
11.17.1 Promega Corporation (US) Company Details
11.17.2 Promega Corporation (US) Business Overview
11.17.3 Promega Corporation (US) Nucleic Acid Multiplex Assay Introduction
11.17.4 Promega Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.17.5 Promega Corporation (US) Recent Development
11.18 Siemens Healthineers (Germany)
11.18.1 Siemens Healthineers (Germany) Company Details
11.18.2 Siemens Healthineers (Germany) Business Overview
11.18.3 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Introduction
11.18.4 Siemens Healthineers (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.18.5 Siemens Healthineers (Germany) Recent Development
11.19 PerkinElmer, Inc. (US)
11.19.1 PerkinElmer, Inc. (US) Company Details
11.19.2 PerkinElmer, Inc. (US) Business Overview
11.19.3 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.19.4 PerkinElmer, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.19.5 PerkinElmer, Inc. (US) Recent Development
11.20 Shimadzu Biotech (Japan)
11.20.1 Shimadzu Biotech (Japan) Company Details
11.20.2 Shimadzu Biotech (Japan) Business Overview
11.20.3 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Introduction
11.20.4 Shimadzu Biotech (Japan) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.20.5 Shimadzu Biotech (Japan) Recent Development
11.21 Antigenix America, Inc. (US)
11.21.1 Antigenix America, Inc. (US) Company Details
11.21.2 Antigenix America, Inc. (US) Business Overview
11.21.3 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.21.4 Antigenix America, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.21.5 Antigenix America, Inc. (US) Recent Development
11.22 Enzo Life Sciences, Inc. (US)
11.22.1 Enzo Life Sciences, Inc. (US) Company Details
11.22.2 Enzo Life Sciences, Inc. (US) Business Overview
11.22.3 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.22.4 Enzo Life Sciences, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.22.5 Enzo Life Sciences, Inc. (US) Recent Development
11.23 Boster Biological Technology (US)
11.23.1 Boster Biological Technology (US) Company Details
11.23.2 Boster Biological Technology (US) Business Overview
11.23.3 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Introduction
11.23.4 Boster Biological Technology (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.23.5 Boster Biological Technology (US) Recent Development
11.24 AYOXXA Biosystems GmbH (Germany)
11.24.1 AYOXXA Biosystems GmbH (Germany) Company Details
11.24.2 AYOXXA Biosystems GmbH (Germany) Business Overview
11.24.3 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Introduction
11.24.4 AYOXXA Biosystems GmbH (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.24.5 AYOXXA Biosystems GmbH (Germany) Recent Development
11.25 Cayman Chemical Company (US)
11.25.1 Cayman Chemical Company (US) Company Details
11.25.2 Cayman Chemical Company (US) Business Overview
11.25.3 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Introduction
11.25.4 Cayman Chemical Company (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025)
11.25.5 Cayman Chemical Company (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Luminex Corporation (US)
Thermo Fisher Scientific Inc. (US)
Illumina, Inc. (US)
Bio-Rad Laboratories, Inc. (US)
QIAGEN N.V. (Netherlands)
Abcam plc (UK)
Becton Dickinson and Company (US)
Merck KGaA Germany
Agilent Technologies Inc. (US)
Meso Scale Diagnostics (US)
Randox Laboratories (UK)
Quanterix (US)
Bio-Techne Corporation (US)
Olink (Sweden)
DiaSorin S.p.A. (Italy)
Seegene (South Korea)
Promega Corporation (US)
Siemens Healthineers (Germany)
Perkinelmer Inc (US)
Shimadzu Biotech (Japan)
Antigenix America, Inc. (US)
Enzo Life Sciences, Inc. (US)
Boster Biological Technology(US)
AYOXXA Biosystems GmbH (Germany)
Cayman Chemical Company (US)
List of Tables
 Table 1. Global Nucleic Acid Multiplex Assay Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Planar Nucleic Acid Assays
 Table 3. Key Players of Bead-Based Nucleic Acid Assays
 Table 4. Key Players of Other Nucleic Acid Assays
 Table 5. Global Nucleic Acid Multiplex Assay Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Nucleic Acid Multiplex Assay Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Nucleic Acid Multiplex Assay Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Nucleic Acid Multiplex Assay Market Share by Region (2020-2025)
 Table 9. Global Nucleic Acid Multiplex Assay Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Nucleic Acid Multiplex Assay Market Share by Region (2026-2031)
 Table 11. Nucleic Acid Multiplex Assay Market Trends
 Table 12. Nucleic Acid Multiplex Assay Market Drivers
 Table 13. Nucleic Acid Multiplex Assay Market Challenges
 Table 14. Nucleic Acid Multiplex Assay Market Restraints
 Table 15. Global Nucleic Acid Multiplex Assay Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Nucleic Acid Multiplex Assay Market Share by Players (2020-2025)
 Table 17. Global Top Nucleic Acid Multiplex Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assay as of 2024)
 Table 18. Ranking of Global Top Nucleic Acid Multiplex Assay Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Nucleic Acid Multiplex Assay Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Nucleic Acid Multiplex Assay, Headquarters and Area Served
 Table 21. Global Key Players of Nucleic Acid Multiplex Assay, Product and Application
 Table 22. Global Key Players of Nucleic Acid Multiplex Assay, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Nucleic Acid Multiplex Assay Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Nucleic Acid Multiplex Assay Revenue Market Share by Type (2020-2025)
 Table 26. Global Nucleic Acid Multiplex Assay Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Nucleic Acid Multiplex Assay Revenue Market Share by Type (2026-2031)
 Table 28. Global Nucleic Acid Multiplex Assay Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Nucleic Acid Multiplex Assay Revenue Market Share by Application (2020-2025)
 Table 30. Global Nucleic Acid Multiplex Assay Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Nucleic Acid Multiplex Assay Revenue Market Share by Application (2026-2031)
 Table 32. North America Nucleic Acid Multiplex Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Nucleic Acid Multiplex Assay Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Nucleic Acid Multiplex Assay Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Nucleic Acid Multiplex Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Nucleic Acid Multiplex Assay Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Nucleic Acid Multiplex Assay Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Nucleic Acid Multiplex Assay Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Nucleic Acid Multiplex Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Nucleic Acid Multiplex Assay Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Nucleic Acid Multiplex Assay Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Luminex Corporation (US) Company Details
 Table 48. Luminex Corporation (US) Business Overview
 Table 49. Luminex Corporation (US) Nucleic Acid Multiplex Assay Product
 Table 50. Luminex Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 51. Luminex Corporation (US) Recent Development
 Table 52. Thermo Fisher Scientific Inc. (US) Company Details
 Table 53. Thermo Fisher Scientific Inc. (US) Business Overview
 Table 54. Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product
 Table 55. Thermo Fisher Scientific Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 56. Thermo Fisher Scientific Inc. (US) Recent Development
 Table 57. Illumina, Inc (US) Company Details
 Table 58. Illumina, Inc (US) Business Overview
 Table 59. Illumina, Inc (US) Nucleic Acid Multiplex Assay Product
 Table 60. Illumina, Inc (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 61. Illumina, Inc (US) Recent Development
 Table 62. Bio-Rad Laboratories, Inc. (US) Company Details
 Table 63. Bio-Rad Laboratories, Inc. (US) Business Overview
 Table 64. Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product
 Table 65. Bio-Rad Laboratories, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 66. Bio-Rad Laboratories, Inc. (US) Recent Development
 Table 67. Qiagen N.V. (Netherlands) Company Details
 Table 68. Qiagen N.V. (Netherlands) Business Overview
 Table 69. Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product
 Table 70. Qiagen N.V. (Netherlands) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 71. Qiagen N.V. (Netherlands) Recent Development
 Table 72. Abcam plc (UK) Company Details
 Table 73. Abcam plc (UK) Business Overview
 Table 74. Abcam plc (UK) Nucleic Acid Multiplex Assay Product
 Table 75. Abcam plc (UK) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 76. Abcam plc (UK) Recent Development
 Table 77. Becton, Dickinson and Company (US) Company Details
 Table 78. Becton, Dickinson and Company (US) Business Overview
 Table 79. Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product
 Table 80. Becton, Dickinson and Company (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 81. Becton, Dickinson and Company (US) Recent Development
 Table 82. Merck KGaA (Germany) Company Details
 Table 83. Merck KGaA (Germany) Business Overview
 Table 84. Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product
 Table 85. Merck KGaA (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 86. Merck KGaA (Germany) Recent Development
 Table 87. Agilent Technologies, Inc. (US) Company Details
 Table 88. Agilent Technologies, Inc. (US) Business Overview
 Table 89. Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product
 Table 90. Agilent Technologies, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 91. Agilent Technologies, Inc. (US) Recent Development
 Table 92. Meso Scale Diagnostics (US) Company Details
 Table 93. Meso Scale Diagnostics (US) Business Overview
 Table 94. Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product
 Table 95. Meso Scale Diagnostics (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 96. Meso Scale Diagnostics (US) Recent Development
 Table 97. Randox Laboratories (UK) Company Details
 Table 98. Randox Laboratories (UK) Business Overview
 Table 99. Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product
 Table 100. Randox Laboratories (UK) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 101. Randox Laboratories (UK) Recent Development
 Table 102. Quanterix (US) Company Details
 Table 103. Quanterix (US) Business Overview
 Table 104. Quanterix (US) Nucleic Acid Multiplex Assay Product
 Table 105. Quanterix (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 106. Quanterix (US) Recent Development
 Table 107. Bio-Techne Corporation (US) Company Details
 Table 108. Bio-Techne Corporation (US) Business Overview
 Table 109. Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product
 Table 110. Bio-Techne Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 111. Bio-Techne Corporation (US) Recent Development
 Table 112. Olink (Sweden) Company Details
 Table 113. Olink (Sweden) Business Overview
 Table 114. Olink (Sweden) Nucleic Acid Multiplex Assay Product
 Table 115. Olink (Sweden) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 116. Olink (Sweden) Recent Development
 Table 117. DiaSorin S.p.A. (Italy) Company Details
 Table 118. DiaSorin S.p.A. (Italy) Business Overview
 Table 119. DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product
 Table 120. DiaSorin S.p.A. (Italy) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 121. DiaSorin S.p.A. (Italy) Recent Development
 Table 122. Seegene (South Korea) Company Details
 Table 123. Seegene (South Korea) Business Overview
 Table 124. Seegene (South Korea) Nucleic Acid Multiplex Assay Product
 Table 125. Seegene (South Korea) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 126. Seegene (South Korea) Recent Development
 Table 127. Promega Corporation (US) Company Details
 Table 128. Promega Corporation (US) Business Overview
 Table 129. Promega Corporation (US) Nucleic Acid Multiplex Assay Product
 Table 130. Promega Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 131. Promega Corporation (US) Recent Development
 Table 132. Siemens Healthineers (Germany) Company Details
 Table 133. Siemens Healthineers (Germany) Business Overview
 Table 134. Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product
 Table 135. Siemens Healthineers (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 136. Siemens Healthineers (Germany) Recent Development
 Table 137. PerkinElmer, Inc. (US) Company Details
 Table 138. PerkinElmer, Inc. (US) Business Overview
 Table 139. PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product
 Table 140. PerkinElmer, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 141. PerkinElmer, Inc. (US) Recent Development
 Table 142. Shimadzu Biotech (Japan) Company Details
 Table 143. Shimadzu Biotech (Japan) Business Overview
 Table 144. Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product
 Table 145. Shimadzu Biotech (Japan) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 146. Shimadzu Biotech (Japan) Recent Development
 Table 147. Antigenix America, Inc. (US) Company Details
 Table 148. Antigenix America, Inc. (US) Business Overview
 Table 149. Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product
 Table 150. Antigenix America, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 151. Antigenix America, Inc. (US) Recent Development
 Table 152. Enzo Life Sciences, Inc. (US) Company Details
 Table 153. Enzo Life Sciences, Inc. (US) Business Overview
 Table 154. Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product
 Table 155. Enzo Life Sciences, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 156. Enzo Life Sciences, Inc. (US) Recent Development
 Table 157. Boster Biological Technology (US) Company Details
 Table 158. Boster Biological Technology (US) Business Overview
 Table 159. Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product
 Table 160. Boster Biological Technology (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 161. Boster Biological Technology (US) Recent Development
 Table 162. AYOXXA Biosystems GmbH (Germany) Company Details
 Table 163. AYOXXA Biosystems GmbH (Germany) Business Overview
 Table 164. AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product
 Table 165. AYOXXA Biosystems GmbH (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 166. AYOXXA Biosystems GmbH (Germany) Recent Development
 Table 167. Cayman Chemical Company (US) Company Details
 Table 168. Cayman Chemical Company (US) Business Overview
 Table 169. Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product
 Table 170. Cayman Chemical Company (US) Revenue in Nucleic Acid Multiplex Assay Business (2020-2025) & (US$ Million)
 Table 171. Cayman Chemical Company (US) Recent Development
 Table 172. Research Programs/Design for This Report
 Table 173. Key Data Information from Secondary Sources
 Table 174. Key Data Information from Primary Sources
 Table 175. Authors List of This Report


List of Figures
 Figure 1. Nucleic Acid Multiplex Assay Picture
 Figure 2. Global Nucleic Acid Multiplex Assay Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nucleic Acid Multiplex Assay Market Share by Type: 2024 VS 2031
 Figure 4. Planar Nucleic Acid Assays Features
 Figure 5. Bead-Based Nucleic Acid Assays Features
 Figure 6. Other Nucleic Acid Assays Features
 Figure 7. Global Nucleic Acid Multiplex Assay Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Nucleic Acid Multiplex Assay Market Share by Application: 2024 VS 2031
 Figure 9. Pharmaceutical & Biotechnology Companies Case Studies
 Figure 10. Hospitals & Research Institutes Case Studies
 Figure 11. Reference Laboratories Case Studies
 Figure 12. Other Case Studies
 Figure 13. Nucleic Acid Multiplex Assay Report Years Considered
 Figure 14. Global Nucleic Acid Multiplex Assay Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Nucleic Acid Multiplex Assay Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Nucleic Acid Multiplex Assay Market Share by Region: 2024 VS 2031
 Figure 17. Global Nucleic Acid Multiplex Assay Market Share by Players in 2024
 Figure 18. Global Top Nucleic Acid Multiplex Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assay as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Nucleic Acid Multiplex Assay Revenue in 2024
 Figure 20. North America Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Nucleic Acid Multiplex Assay Market Share by Country (2020-2031)
 Figure 22. United States Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Nucleic Acid Multiplex Assay Market Share by Country (2020-2031)
 Figure 26. Germany Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Nucleic Acid Multiplex Assay Market Share by Region (2020-2031)
 Figure 34. China Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Nucleic Acid Multiplex Assay Market Share by Country (2020-2031)
 Figure 42. Mexico Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Nucleic Acid Multiplex Assay Market Share by Country (2020-2031)
 Figure 46. Turkey Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Nucleic Acid Multiplex Assay Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Luminex Corporation (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 50. Thermo Fisher Scientific Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 51. Illumina, Inc (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 52. Bio-Rad Laboratories, Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 53. Qiagen N.V. (Netherlands) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 54. Abcam plc (UK) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 55. Becton, Dickinson and Company (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 56. Merck KGaA (Germany) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 57. Agilent Technologies, Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 58. Meso Scale Diagnostics (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 59. Randox Laboratories (UK) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 60. Quanterix (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 61. Bio-Techne Corporation (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 62. Olink (Sweden) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 63. DiaSorin S.p.A. (Italy) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 64. Seegene (South Korea) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 65. Promega Corporation (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 66. Siemens Healthineers (Germany) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 67. PerkinElmer, Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 68. Shimadzu Biotech (Japan) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 69. Antigenix America, Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 70. Enzo Life Sciences, Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 71. Boster Biological Technology (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 72. AYOXXA Biosystems GmbH (Germany) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 73. Cayman Chemical Company (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2020-2025)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Nucleic Acid Multiplex Assays Market Research Report 2025
Global Nucleic Acid Based Multiplex Assays Market Insights Forecast to 2030
Global Nucleic Acid Testing Market Research Report 2024
Global Protein Multiplex Assay Market Research Report 2024
Global Cell Multiplex Assay Technology Market Research Report 2025
Global Protein Multiplex Assays Market Research Report 2025
Global Nucleic Acid Detection Reagents Market Research Report 2024
Global Protein Multiplex Assay Technology Market Research Report 2024
Global Automatic Nucleic Acid Detection System Market Research Report 2025
Global Multiplex PCR Kit Market Research Report 2024
Global Nucleic Acid Extraction Reagents Market Research Report 2024
Nucleic Acid Testing Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nucleic Acid Based Gene Therapeutics Market Research Report 2024
Global Nucleic Acid Extraction and Purification Reagent Market Research Report 2024
Global Nucleic Acid Nanotechnology Market Research Report 2024
Global Nucleic Acid Preservation Reagent Market Research Report 2025
Global Small Nucleic Acid Based Drug Market Research Report 2025
Global Nucleic Acid Sampling Swab Market Research Report 2024
Multiplex Real Time PCR Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nucleic Acid Electrophoresis System Market Research Report 2024

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ecology Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29H6022
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions